Inhibitory Activity Of Roselle Flower (Hibiscus Sabdariffa L.) Aqueous Extract - Sodium Alginate Gel Against Staphylococcus aureus ATCC 25923
Downloads
Staphylococcus aureus is one type of bacterium that causes skin infections resistant to some antibiotics. This encourages research to find new antibacterials by using substances from natural sources, often called medicinal plants. Aqueous extract of Roselle (Hibiscus sabdariffa L.) flower (AERF) was selected as one of natural ingredients for antibacterial in gel dosage form, in which sodium alginate was used as a matrix base. In this study, determination of the sodium alginate concentration effects (2.5%, 3% and 3.5%) on the properties of the gel was performed. The characteristics evaluated included pH, viscosity, and dispersive power; that should be met standard requirement and the gel ability to inhibit Staphylococcus aureus ATCC 25923 growths. A diffusion test method was used to determine the Minimum Inhibitory Concentration (MIC) of the AERF powder against the test bacteria. The study results showed that AERF gel preparation with a composition of 3% sodium alginate and 3% roselle extract had better properties (pH, viscosity, and dispersive power) than the matrix and extract concentrations of 2.5% and 3.5% respectively. It was found that the optimum formula obtained a MIC of 0.04 mg/ml. In line with these results, it is expected that the AERF gel preparation will be stable, safe, and acceptable when used and might be recommended as antibacterial topical dosage form against Staphylococcus aureus. In the future, inhibitory activity against resistant pathogenic bacteria could be evaluated and developed.
Brooks, G.F, Janet, S.B, and Stephen A.M. (2007) ‘Medical Microbiology: Jawetz, Melnick and Adelberg'. Ed. 23. Translated to Bahasa Indonesia by Mudhardi, E., Kuntaman, Wasito, E.B., Mertaniasih, N.M., Harsono, S., and Alimsardjono, L., Medical Books Publisher.
Bartlett, A. H., and Hulten, K. G. (2010) 'Staphylococcus aureus Pathogenesis: Secretion Systems, Adhesins, and Invasins', Pediatric Infectious Dis ease Journal, Vol. 29, No. 9, pp. 860-861.
Chiller, K., Selkin, B, A., and Murakawa, G, J. (2001) ‘Skin Microflora and Bacterial Infections of the Skin', Journal of Investigative Dermatology Symposium Proceedings, Vol. 6, No. 3, pp. 170-174.
Cusnie, T.P.T., and Lamb, A.J., (2005), ‘Antimicrobial activity of flavonoids', International Journal of Antimicrobial Agents, Vol. 26, pp. 343-356.
Da-Costa-Rocha, I., Bonnlaender, B., Sievers, H., Pischel, I., and Heinrich, M. (2014) ‘Hibiscus sabdariffa L. - A phytochemical and pharmacological review', Food Chemistry, Vol. 165, pp. 424-443.
Fischbach, M. A., and Walsh, C. T. (2009) ‘Antibiotics for Emerging Pathogens', Science, Vol. 325, pp. 1089-1093.
Kayser, F.H., Bienz, K.A., Eckert, J., and Zinkernagel, R. M. (2005) ‘Color of Atlas Medical Microbiology', Stuttgart: Thieme Medical Publishers, pp. 229-243.
Navarro G.V.M., Rojas, G.L. Gerardo Z., Aviles, M., Fuentes, M., Herrera, A. and Jimenez, E. (2006) ‘Antifungal and antibacterial activity of four selected Mexican medicinal plants' Pharmaceutical Biology, Vol. 44, pp. 297-300.
Nuria, M. C., Faizatun, A. and Sumantri. (2009) "Uji Aktivitas Antibakteri Ekstrak Etanol Daun Jarak Pagar (Jatropha curcas L.) Terhadap Bakteri Staphylococcus aureus ATCC 25923, Escherichia coli ATCC 25922, and Salmonella thypi ATCC 1408”, Antibacterial Activity Test of Jatropha Leaves' Etanol Extract towards Bacterium Staphylococcus aureus ATCC 25923, Escherichia coli ATCC 25922 and Salmonella thypi]. Mediagro, Vol.6, No. 2, pp. 26-37.
Rowe, R.C., Sheskey, P.J. and Quinn, M.E. (2009) "Handbook of Pharmaceutical Excipients”, 6th Ed. London: Pharmaceutical Press, pp. 622-624.
Tan, X., Feldman, S. R., Chang, J. and Balkrishnan, R. (2012) "Topical drug delivery systems in dermatology: a review of patient adherence issues”, Expert Opinion on Drug Delivery, Vol. 9, No. 10, pp. 1263-1271
BIKF by Unair is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
1. The journal allows the author to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions
3. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution Share-Alike (CC BY-SA).
4. The Creative Commons Attribution Share-Alike (CC BY-SA) license allows re-distribution and re-use of a licensed work on the conditions that the creator is appropriately credited and that any derivative work is made available under "the same, similar or a compatible license”. Other than the conditions mentioned above, the editorial board is not responsible for copyright violation.